Experience

Gracell Biotechnologies Agrees to Acquisition by AstraZeneca for up to $1.2 Billion

December 26, 2023

Cooley advised Gracell Biotechnologies, a global clinical-stage biopharmaceutical company dedicated to developing innovative cell therapies for the treatment of cancer and autoimmune diseases, on its definitive agreement to be acquired by AstraZeneca.

Read more

Related contacts

Rama Padmanabhan
Partner, San Diego
Rowook Park
Partner, San Diego
Izzy Lubarsky
Partner, New York
Brittany K. Wightman
Associate, San Diego
Rajdeep Roger Bains
Associate, San Diego
Melissa Meza
Associate, San Diego
Will Cai
Partner, Hong Kong
Patrick Loofbourrow
Partner, Singapore
Jie Zhang
Partner, Hong Kong
Hilda Li
Associate, Hong Kong
Samantha Zhang
Associate, Singapore
Alessandra Murata
Partner, Palo Alto
Charity Williams
Partner, San Diego
Xander Lee
Partner, Los Angeles Santa Monica
Phil Mitchell
Partner, New York
Megan Browdie
Partner, Washington, DC
Christopher Kimball
Partner, Washington, DC
Ross Eberly
Partner, Los Angeles Santa Monica
Lei Shen
Partner, Chicago
Natasha Leskovsek
Of Counsel, Washington, DC
Rena Kaminsky
Special Counsel, Palo Alto
Stella Sarma
Special Counsel, Brussels
Christine Graham
Special Counsel, London
Andrew Epstein
Special Counsel, Seattle
Dillon Martinson
Special Counsel, Washington, DC
Ajay Athavale
Associate, San Francisco
Amanda Griggs
Associate, New York
Sara Kim
Associate, Los Angeles Downtown
Patrick Sharma
Associate, Los Angeles Santa Monica
Allison Kutner
Associate, New York
Eileen Leman
Associate, Los Angeles Downtown
Daniel Lac
Associate, San Diego
Sarah Oliai
Associate, Washington, DC

Related Practices & Industries

Gracell Biotechnologies Announces Up to $150 Million Private Placement Financing Joined by Syndicate of Premier Healthcare Investors

August 9, 2023

Cooley advised Gracell Biotechnologies, a global clinical-stage biopharmaceutical company dedicated to developing innovative and highly efficacious cell therapies for the treatment of cancer and autoimmune diseases, on its private placement financing of up to $150 million.

Read more

Related contacts

Will Cai
Partner, Hong Kong
Jie Zhang
Partner, Hong Kong
Francis Wheeler
Partner, Colorado
Hilda Li
Associate, Hong Kong
Harvey Yao
Associate, Hong Kong
Samantha Zhang
Associate, Singapore
Zhengyang Li
Senior Legal Assistant, Hong Kong

Related Practices & Industries

Structure Therapeutics – $185.3 Million IPO

February 9, 2023

San Francisco – February 9, 2023 Cooley advised Structure Therapeutics, a clinical-stage global biopharmaceutical company, on its $185.3 million initial public offering, including the full exercise of the underwriters’ option to purchase additional American depositary shares. Lawyers Charlie Kim, Patrick Loofbourrow, Andrew Harline and Su Lian Lu led the Cooley team.

The offering marks the first sizable US life sciences IPO this year. Structure Therapeutics will use the proceeds to develop new oral therapies for the treatment of various diseases, including those impacting the metabolic, cardiovascular and pulmonary systems. Its lead product candidate targets Type 2 diabetes and obesity.

Structure Therapeutics aims to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages structure-based drug discovery and computational chemistry expertise, enabling it to build a pipeline of product candidates. The company currently focuses on G-protein-coupled receptors as a therapeutic target class.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has nearly 1,400 lawyers across 18 offices in the United States, Asia and Europe, and a total workforce of more than 3,000.

Related contacts

Charlie Kim
Partner, San Diego
Patrick Loofbourrow
Partner, Singapore
Andrew Harline
Partner in Charge – Singapore, Singapore
Su Lian Lu
Special Counsel, Los Angeles Santa Monica
Xander Lee
Partner, Los Angeles Santa Monica
Jie Zhang
Partner, Hong Kong
Phil Mitchell
Partner, New York
Aaron Pomeroy
Partner, Colorado
Carlos Ramirez
Partner, San Diego
Ryan Blair
Partner, San Diego
Joshua Mates
Partner, San Francisco
Mark Ballantyne
Partner, Reston
Nicola Squire
Partner, London
Francis Wheeler
Partner, Colorado
Will Cai
Partner, Hong Kong
Thomas Welk
Senior Counsel, San Diego
Natasha Leskovsek
Of Counsel, Washington, DC
Dani Nazemian
Special Counsel, San Diego
Randy Sabett
Special Counsel, Washington, DC
Bin Wang
Special Counsel, Palo Alto
Rebecca Ross
Special Counsel, Washington, DC
Lisa Yuan
Special Counsel, Beijing
Jennifer Shanley
Special Counsel, New York
Christine Turner
Associate, Colorado
Vince Flynn
Associate, San Diego
Ivy Wang
Associate, Shanghai
Rick Jantz
Associate, Los Angeles Santa Monica
Yuan Dai
Associate, Shanghai
Cara Buchicchio
Associate, New York
Megan Drill
Associate, San Diego
Daniel Gillon
Associate, San Diego
Dionne A. Thomas
Associate, San Diego
Cristina Ferruolo
Associate, San Diego
Brian Lau
International Legal Project Manager, Hong Kong
Jessica Wade
Paralegal Specialist, San Diego
Kate Walther
Paralegal Specialist, San Diego
Lunga Su
Associate, Shanghai
Christine S. Kim
Associate, San Diego
Andy Zachrich
Associate, San Diego

Related Practices & Industries

TI Cloud – $71.7 Million IPO

July 27, 2022

Cooley advised TI Cloud on its $71.7 million initial public offering of 43,530,000 shares at a public offering price of HK$12.85 per share. TI Cloud offers a broad array of cloud-native customer contact solutions that enable enterprises to engage in multichannel customer interactions. Partners Michael Yu and Will Cai led the Cooley team.

Related contacts

Philip Kwan
Senior Legal Assistant, Hong Kong
Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Brian Lau
International Legal Project Manager, Hong Kong
Jie Zhang
Partner, Hong Kong
Keke Wu
Associate, Hong Kong
Ying Liu
Associate, Hong Kong
Will Cai
Partner, Hong Kong

Related Practices & Industries

TI Cloud – HK$559.4 Million IPO

July 1, 2022

Cooley advised TI Cloud, a cloud-native customer contact solution provider, on its HK$559.4 million ($71.7 million) initial public offering of 43,530,000 shares (subject to an overallotment option to issue an additional 6,529,400 shares), which now trade on the Hong Kong Stock Exchange. Partners Michael Yu and Will Cai led the Cooley team advising TI Cloud, which also included Jie Zhang, Ying Liu, Keke Wu, Zhengyang Li, Lingyi Lin and Philip Kwan. 
Read more

Related contacts

Michael Yu
Partner in Charge – Hong Kong, Hong Kong
Will Cai
Partner, Hong Kong
Xander Lee
Partner, Los Angeles Santa Monica
Francis Wheeler
Partner, Colorado
Jie Zhang
Partner, Hong Kong
Ying Liu
Associate, Hong Kong
Zhengyang Li
Senior Legal Assistant, Hong Kong
Rick Jantz
Associate, Los Angeles Santa Monica
Philip Kwan
Senior Legal Assistant, Hong Kong

Related Practices & Industries

View more